| ADR Ontology |
| ADR Term |
Breast hyperplasia |
| ADR ID |
BADD_A00685 |
| ADR Hierarchy |
|
| Description |
A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma. [MeSH] |
| MedDRA Code |
10006256 |
| MeSH ID |
D002285
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Bilateral mammary hyperplasia | Breast hyperplasia | Hyperplasia breast | Mammary hyperplasia bilateral | Atypical breast hyperplasia | Atypical ductal hyperplasia | Atypical lobular hyperplasia | Carcinoma, Intraductal, Noninfiltrating | Carcinoma, Intraductal | Carcinomas, Intraductal | Intraductal Carcinoma | Intraductal Carcinomas | DCIS | Ductal Carcinoma In Situ | Intraductal Carcinoma, Noninfiltrating | Carcinoma, Noninfiltrating Intraductal | Carcinomas, Noninfiltrating Intraductal | Intraductal Carcinomas, Noninfiltrating | Noninfiltrating Intraductal Carcinoma | Noninfiltrating Intraductal Carcinomas | Atypical Ductal Hyperplasia | Atypical Ductal Hyperplasias | Ductal Hyperplasia, Atypical | Ductal Hyperplasias, Atypical | Hyperplasia, Atypical Ductal | Hyperplasias, Atypical Ductal |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Alanine aminotransferase 1 | P24298 | Not Available |
|
| Drugs Leading to the ADR |
|
|
